Your browser doesn't support javascript.
loading
Reduced clone size upon BTK inhibitor resistance mutations relates to toxicity caused by inherited PLCG2 gain-of-function variations.
Smith, C I Edvard; Zain, Rula.
Affiliation
  • Smith CIE; Department of Laboratory Medicine, Karolinska Institutet, and Karolinska ATMP Center, ANA Futura, Huddinge, Sweden.
  • Zain R; Department of Laboratory Medicine, Karolinska Institutet, and Karolinska ATMP Center, ANA Futura, Huddinge, Sweden.
Eur J Haematol ; 113(1): 130-131, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38529725
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Kinase Inhibitors / Phospholipase C gamma / Gain of Function Mutation / Agammaglobulinaemia Tyrosine Kinase Limits: Humans Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2024 Document type: Article Affiliation country: Suecia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Kinase Inhibitors / Phospholipase C gamma / Gain of Function Mutation / Agammaglobulinaemia Tyrosine Kinase Limits: Humans Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2024 Document type: Article Affiliation country: Suecia